Age-related changes in male gonadal function. Implications for therapy

Area of Science:

• Endocrinology
• Aging Research
• Men's Health

Background:

• Men experience gradual decline in testosterone production with aging, unlike women's menopause.
• Cross-sectional studies suggest a partial decrease in testosterone levels in aging men, but findings are inconsistent.
• Discrepancies in studies are attributed to variations in design, sample size, assays, and patient selection.

Purpose of the Study:

• To explore the age-associated changes in male testosterone production.
• To review potential mechanisms behind declining testosterone levels in aging men.
• To evaluate the benefits and risks of testosterone replacement therapy (TRT) in hypogonadal men.

Main Methods:

• Review of existing cross-sectional and observational studies on aging and male hormone levels.
• Analysis of proposed physiological and environmental factors contributing to testosterone decline.
• Assessment of evidence for and against testosterone replacement therapy in older men.

Main Results:

• While testicular androgen production is largely maintained, a partial decrease in testosterone levels with aging is reported in some studies.
• Potential causes for age-related testosterone decline include hypothalamic-pituitary-testicular axis defects, increased sex hormone-binding globulin, environmental factors, medications, and chronic illness.
• TRT may improve bone density, muscle strength, well-being, and metabolic profile in hypogonadal men.

Conclusions:

• Testosterone replacement therapy in hypogonadal men offers potential benefits but requires careful consideration of risks like erythrocytosis, sleep apnea, and prostate issues.
• Androgen replacement should be administered cautiously in elderly men with hypogonadism pending results from rigorous prospective studies.
• Further well-controlled research is necessary to establish definitive guidelines for TRT in aging men.